ArticleNature communications2023

Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.

Thiago Moreno L Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.